×
S&P 500   4,132.28 (+1.83%)
DOW   32,996.64 (+1.10%)
QQQ   307.12 (+2.60%)
AAPL   148.57 (+3.33%)
MSFT   270.79 (+1.84%)
FB   194.12 (+1.30%)
GOOGL   2,233.37 (+3.60%)
AMZN   2,266.90 (+2.04%)
TSLA   754.33 (+6.58%)
NVDA   186.89 (+4.69%)
BABA   93.04 (-1.52%)
NIO   16.45 (+2.62%)
AMD   101.68 (+2.97%)
CGC   4.91 (-11.53%)
MU   73.07 (+3.50%)
T   21.18 (-0.66%)
GE   77.97 (+1.25%)
F   13.59 (+3.58%)
DIS   108.52 (+2.76%)
AMC   14.03 (+14.72%)
PFE   53.58 (-0.76%)
PYPL   84.77 (+5.41%)
NFLX   194.18 (+1.45%)
S&P 500   4,132.28 (+1.83%)
DOW   32,996.64 (+1.10%)
QQQ   307.12 (+2.60%)
AAPL   148.57 (+3.33%)
MSFT   270.79 (+1.84%)
FB   194.12 (+1.30%)
GOOGL   2,233.37 (+3.60%)
AMZN   2,266.90 (+2.04%)
TSLA   754.33 (+6.58%)
NVDA   186.89 (+4.69%)
BABA   93.04 (-1.52%)
NIO   16.45 (+2.62%)
AMD   101.68 (+2.97%)
CGC   4.91 (-11.53%)
MU   73.07 (+3.50%)
T   21.18 (-0.66%)
GE   77.97 (+1.25%)
F   13.59 (+3.58%)
DIS   108.52 (+2.76%)
AMC   14.03 (+14.72%)
PFE   53.58 (-0.76%)
PYPL   84.77 (+5.41%)
NFLX   194.18 (+1.45%)
S&P 500   4,132.28 (+1.83%)
DOW   32,996.64 (+1.10%)
QQQ   307.12 (+2.60%)
AAPL   148.57 (+3.33%)
MSFT   270.79 (+1.84%)
FB   194.12 (+1.30%)
GOOGL   2,233.37 (+3.60%)
AMZN   2,266.90 (+2.04%)
TSLA   754.33 (+6.58%)
NVDA   186.89 (+4.69%)
BABA   93.04 (-1.52%)
NIO   16.45 (+2.62%)
AMD   101.68 (+2.97%)
CGC   4.91 (-11.53%)
MU   73.07 (+3.50%)
T   21.18 (-0.66%)
GE   77.97 (+1.25%)
F   13.59 (+3.58%)
DIS   108.52 (+2.76%)
AMC   14.03 (+14.72%)
PFE   53.58 (-0.76%)
PYPL   84.77 (+5.41%)
NFLX   194.18 (+1.45%)
S&P 500   4,132.28 (+1.83%)
DOW   32,996.64 (+1.10%)
QQQ   307.12 (+2.60%)
AAPL   148.57 (+3.33%)
MSFT   270.79 (+1.84%)
FB   194.12 (+1.30%)
GOOGL   2,233.37 (+3.60%)
AMZN   2,266.90 (+2.04%)
TSLA   754.33 (+6.58%)
NVDA   186.89 (+4.69%)
BABA   93.04 (-1.52%)
NIO   16.45 (+2.62%)
AMD   101.68 (+2.97%)
CGC   4.91 (-11.53%)
MU   73.07 (+3.50%)
T   21.18 (-0.66%)
GE   77.97 (+1.25%)
F   13.59 (+3.58%)
DIS   108.52 (+2.76%)
AMC   14.03 (+14.72%)
PFE   53.58 (-0.76%)
PYPL   84.77 (+5.41%)
NFLX   194.18 (+1.45%)
LON:MTPH

Midatech Pharma (MTPH) Share Forecast, Price & News

GBX 9.88
+0.13 (+1.33%)
(As of 05/27/2022 04:26 PM ET)
Add
Compare
Today's Range
9.50
10.90
50-Day Range
9.75
13.75
52-Week Range
9.50
51.95
Volume
468,250 shs
Average Volume
174,488 shs
Market Capitalization
£9.73 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive MTPH News and Ratings via Email

Sign-up to receive the latest news and ratings for Midatech Pharma and its competitors with MarketBeat's FREE daily newsletter.

Midatech Pharma logo

About Midatech Pharma

Midatech Pharma plc, a drug delivery technology company, focuses on the research and development of medicines in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant for topical application in psoriasis; MTD211, a long-acting formulation of brexpiprazole for the treatment of schizophrenia and adjunctive treatment of major depressive disorder; and MTD219, a long-acting formulation of tacrolimus used to lower the risk of organ transplant rejection. It also offers drug delivery platforms, such as Q-Sphera, a polymer microsphere microtechnology used for sustained release drug delivery; MidaSolve, an oligosaccharide nanotechnology used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore, a gold nanoparticle used for targeting sites of disease by using chemotherapeutic agents or immunotherapeutic agents. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
18
Year Founded
N/A

Sales & Book Value

Annual Sales
£578 thousand
Cash Flow
GBX 10.34 per share
Book Value
GBX 10.60 per share

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
£9.73 million
Optionable
Not Optionable

Company Calendar

Last Earnings
9/10/2020
Today
5/27/2022

MarketRank

Overall MarketRank

1.13 out of 5 stars

Analyst Opinion: 0.0Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -













Midatech Pharma (LON:MTPH) Frequently Asked Questions

How were Midatech Pharma's earnings last quarter?

Midatech Pharma plc (LON:MTPH) released its quarterly earnings data on Thursday, September, 10th. The company reported ($64.00) earnings per share (EPS) for the quarter.
View Midatech Pharma's earnings history
.

Who are Midatech Pharma's key executives?
Midatech Pharma's management team includes the following people:
  • Mr. Stephen A. Stamp, CEO, CFO, Company Sec. & Director (Age 60, Pay $193.17k)
  • Dr. Daniel Palmer MBA, Ph.D., VP of Technology
  • Dr. Dmitry Zamoryakhin M.D., Chief Scientific Officer (Age 42)
  • Dr. Tim Sparey Ph.D., Chief Bus. Officer
  • Mr. Justin Barry BSc (Hons.), MBIOL, CBIOL, QP, Head of Manufacturing
  • Mr. David Benharris, Pres of Midatech Pharma US Inc (Age 57)
  • Ms. Fiona Sharp, Group Financial Controller
What other stocks do shareholders of Midatech Pharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Midatech Pharma investors own include Aldeyra Therapeutics (ALDX), Barclays (BARC), Telefonaktiebolaget LM Ericsson (publ) (ERIC), Futura Medical (FUM), Lloyds Banking Group (LLOY), Midatech Pharma (MTP), Intec Pharma (NTEC), Pearson (PSON), Royal Mail (RMG) and AON (AON).

What is Midatech Pharma's stock symbol?

Midatech Pharma trades on the London Stock Exchange (LON) under the ticker symbol "MTPH."

How do I buy shares of Midatech Pharma?

Shares of MTPH and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Midatech Pharma's stock price today?

One share of MTPH stock can currently be purchased for approximately GBX 9.88.

How much money does Midatech Pharma make?

Midatech Pharma has a market capitalization of £9.73 million and generates £578 thousand in revenue each year.

How many employees does Midatech Pharma have?

Midatech Pharma employs 18 workers across the globe.

What is Midatech Pharma's official website?

The official website for Midatech Pharma is www.midatechpharma.com.

How can I contact Midatech Pharma?

Midatech Pharma's mailing address is 65 Innovation Drive, Milton Park, ABINGDON, OX14 4RQ, United Kingdom. The company can be reached via phone at +44-1235-841575.

This page was last updated on 5/27/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.